Industry Category
Business Keywords
Company Description
Ultivue by Vizgen is at the forefront of biotechnology research, driving innovation in spatial biology and multi-omics. Located at 763D Concord Ave, Cambridge, MA 02138, US, Ultivue by Vizgen is dedicated to providing researchers with advanced tools for unlocking insights into human biology and achieving breakthroughs in understanding complex diseases. The company’s commitment to innovation ensures that it remains a key player in the rapidly evolving field of biotechnology.
Through pioneering MERFISH technology and the MERSCOPE® Platform for in situ single-cell spatial genomics, alongside high-fidelity InSituPlex® assays and AI-driven STARVUE™ spatial image analysis technology, Ultivue by Vizgen delivers unparalleled solutions. These technologies provide high-confidence, quantitative data with exceptional accuracy, robustness, and sensitivity, empowering foundational and clinical research. Ultivue by Vizgen’s dedication to pushing the boundaries of spatial biology solidifies its position as an industry leader.
Ultivue by Vizgen continues to expand its capabilities and impact in the biotechnology sector. The company is committed to fostering advancements in spatial omics, whole slide imaging, IHC, phenotyping, and more, ensuring that researchers have access to the best resources available. We invite the management team at Ultivue by Vizgen to create a customized and exclusive company showcase and product listing on our platform to further highlight your innovative solutions.
Ultivue by Vizgen est à l'avant-garde de la recherche biotechnologique, stimulant l'innovation dans la biologie spatiale et la multi-omique. Située au 763D Concord Ave, Cambridge, MA 02138, États-Unis, Ultivue by Vizgen se consacre à fournir aux chercheurs des outils avancés pour déverrouiller des connaissances sur la biologie humaine et réaliser des percées dans la compréhension des maladies complexes. L'engagement de l'entreprise envers l'innovation garantit qu'elle reste un acteur clé dans le domaine de la biotechnologie en évolution rapide.
Grâce à la technologie pionnière MERFISH et à la plateforme MERSCOPE® pour la génomique spatiale unicellulaire in situ, ainsi qu'aux tests InSituPlex® haute fidélité et à la technologie d'analyse d'images spatiales STARVUE™ basée sur l'IA, Ultivue by Vizgen propose des solutions inégalées. Ces technologies fournissent des données quantitatives de haute confiance avec une précision, une robustesse et une sensibilité exceptionnelles, renforçant la recherche fondamentale et clinique. Le dévouement d'Ultivue by Vizgen à repousser les limites de la biologie spatiale consolide sa position de leader du secteur.
Ultivue by Vizgen continue d'étendre ses capacités et son impact dans le secteur de la biotechnologie. L'entreprise s'engage à favoriser les progrès dans l'omique spatiale, l'imagerie de lames entières, l'IHC, le phénotypage et plus encore, garantissant ainsi aux chercheurs l'accès aux meilleures ressources disponibles. Nous invitons l'équipe de direction d'Ultivue by Vizgen à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre davantage en valeur vos solutions innovantes.
Key Personnel / Employees
Compare Companies Side by Side
Compare Ultivue by Vizgen with 3 companies in Biotechnology-Research
| Comparison Field |
Ultivue by VizgenMain Company |
HematogenixView Profile |
Indica LabsView Profile |
Reveal BiosciencesView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2011 | ||
|
Company Size
|
— | 51-200 | 51-200 | 11-50 |
|
City
|
Cambridge, MA | Tinley Park, IL | Albuquerque, New Mexico | San Diego, CA |
|
Country
|
United States | United States | United States | |
|
Skills & Keywords
Comparing with main company
|
17 Total Skills
Spatial Biology
Multi-Omics
MERFISH Technology
In Situ Genomics
Biotechnology Research
Spatial Omics
Digital Pathology
Whole Slide Imaging
IHC
Phenotyping
Immunohistochemistry
Image Analysis
Biomarkers
Multiplexing
Immunofluorescence
Assay Development
Spatial Proteomics
|
14 Total
14 Unique
Unique Skills:
CAP – Accredited
CLIA – Certified
Cytogenetics
FISH
Flow Cytometry
GCP – Compliant
+8
|
6 Total
6 Unique
Unique Skills:
Artificial Intelligence
Chromogenic in situ hybridization (CISH)
Fluorescence in situ hybridization (FISH)
Image Management
Pharma Services
Software Development
|
16 Total
16 Unique
Unique Skills:
Antibody Validation
artificial intelligence
Biomarker Quantification
Deep Learning
Diagnostics
Digital Assays
+10
|
4
Total Companies2011
Oldest Founded1
Countries49
Unique SkillsSimilar Companies
Other organizations in the same industry
SUCCIPRO
Biotechnology-ResearchA spin-off company developing first-in class succinate-modulating therapies for inflammatory and met...
Exosome Diagnostics, a subsidiary of mdxhealth
Biotechnology-ResearchExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HGPCa and gu...
Alternative Company Names
This company is also known as